Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Morlat

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Vaccine|January 27, 2009
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi surveyP Duchet-Niedziolka, O Launay, Z Coutsinos, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
HIV Medicine|May 18, 2016
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]L Michel, C Lions, M Winnock, et al.
HIV Medicine|September 15, 2016
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patientsV Bouteloup, C Sabin, A Mocroft, et al.
Vaccine|January 27, 2009
Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi surveyP Duchet-Niedziolka, O Launay, Z Coutsinos, et al.
HIV Medicine|December 8, 2017
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)E Rosenthal, C Fougerou-Leurent, A Renault, et al.
Pageof 18